Pulse Biosciences, Inc. Increase (Decrease) in Contract with Customer, Liability
Pulse Biosciences, Inc. (PLSE) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2024-05-07
- Pulse Biosciences, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2023-12-31 was $0.00.
- Pulse Biosciences, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2023-06-30 was -$4.00K, a 125.00% decline year-over-year.
- Pulse Biosciences, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was $0.00.
- Pulse Biosciences, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was -$16.00K, a 200.00% decline from fiscal 2021.
- Pulse Biosciences, Inc. increase (decrease) in contract with customer, liability for fiscal 2021 was $16.00K.
- Pulse Biosciences, Inc. increase (decrease) in contract with customer, liability for fiscal 2020 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 2 quarters · filed 2024-05-07 | $0.00 derived: sum of 3 quarters · filed 2024-05-07 | -$4.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | -$4.00K derived: sum of 3 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$4.00K derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | -$38.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | -$38.00K derived: sum of 3 quarters · filed 2024-05-07 | -$32.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | $4.00K 10-Q · filed 2024-05-07 | -$34.00K derived: sum of 2 quarters · filed 2024-05-07 | -$28.00K derived: sum of 3 quarters · filed 2024-05-07 | -$12.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$32.00K derived: sum of 2 quarters · filed 2024-03-28 | -$16.00K derived: sum of 3 quarters · filed 2024-03-28 | -$16.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $22.00K derived: sum of 2 quarters · filed 2023-11-13 | $22.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $16.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $16.00K 10-K · filed 2023-03-31 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |